WASHINGTON - The U.S. Food and Drug Administration said Tuesday it has approved the emergency use of an additional dose of coronavirus vaccines separately developed by Pfizer Inc. and Moderna Inc., with people aged 50 or older eligible for the fourth shots.
Sorry. This article is no longer available.
Sorry, this article was first published more than three months ago and is temporarily unavailable.
Once the upcoming introduction of a paid membership system is fully operational, paid members will have access to all our stories.
Free Membership Provides
Newsletter from Editorial Team and access to archive articles from past three months.
By continuing, you agree to the Terms of Use,
and Privacy Policy.
